Flash Finance

Crop Life Science LimitedCLSLCorporate

Pesticides / Agrochemicals - Indian Latest results: Mar 2026 8 quarters of data
Consolidated Standalone
₹64.45
MCap ₹110 Cr · P/E 15.8
Crop Life Science Limited — Stock analysis & AI research Crop Life Science Limited — Seasonality — best & worst months Crop Life Science Limited — Live exchange announcements
🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹87 Cr
Sales · Mar 2026
-7.4% YoY
₹9 Cr
Operating Profit · Mar 2026
+12.5% YoY
10.3%
OPM % · Mar 2026
+21.2% YoY
₹4 Cr
Net Profit · Mar 2026
+33.3% YoY
₹2.19
EPS · Mar 2026
+17.7% YoY

📝 Crop Life Science Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Crop Life Science Limited reported revenue of ₹87 crore for the quarter ended March 2026 (Q4 FY26), down 7.4% from ₹94 crore in the same quarter last year.

Net profit rose 33.3% year-on-year to ₹4 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹2.19.

Operating profit stood at ₹9 crore — an operating margin (OPM) of 10.3%, compared with 8.5% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹207 crore with a net profit of ₹7 crore.

Valuation snapshot

At the current price of ₹64.45, CLSL has a market capitalisation of ₹110 crore and a trailing P/E of about 15.8.

Within the Pesticides / Agrochemicals - Indian industry, it is the 18th-largest of the 19 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 70.01%, public shareholders 29.99% of Crop Life Science Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹110 Cr
Current Price ?
₹64.5
P/E ?
15.78below ind
Industry P/E ?
17.40
P/B ?
1.30
P/S ?
0.53
P/FCF ?
-27.62
Enterprise Value ?
₹167 Cr
EV/EBITDA ?
9.85
PEG ?
0.79
Earnings Yield ?
7.8%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹207 Cr
OPM ?
8.2%
Profit after tax (TTM) ?
₹7 Cr
EPS (TTM) ?
₹4.08
ROCE ?
12.0%
ROE ?
8.2%
ROA ?
3.4%
Growth
Sales — latest qtr ?
₹87 Cr
PAT — latest qtr ?
₹4 Cr
YoY qtr sales growth ?
-7.4%
YoY qtr profit growth ?
33.3%
Sales growth (3y) ?
17%
Sales growth (5y) ?
14%
Profit growth (3y) ?
20%
Profit growth (5y) ?
14%
Financial Health
Debt ?
₹57 Cr
Debt to Equity ?
0.67
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
70.01%
Change in promoter holding ?
0.00%
Pledged percentage ?
N/A
Market
Return 3 months ?
5.7%
Return 6 months ?
45.6%

🗓️ Quarterly results (8 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026 YoY % QoQ %
Sales 7952971011069412087 -7.4% —
Operating Profit 57668889 +12.5% —
Other Income 01110111 +0.0% —
Interest 12122233 +50.0% —
Depreciation 13222222 +0.0% —
Profit Before Tax 23444546 +20.0% —
Net Profit 13333334 +33.3% —
EPS 0.782.611.961.562.011.861.882.19 +17.7% —
OPM % 6.3% 13.5% 6.2% 5.9% 7.5% 8.5% 6.7% 10.3% +21.2% —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 12171717 +0.0%
Reserves 29556168 +11.5%
Borrowings 27344457 +29.5%
Other Liabilities 34675563 +14.5%
Total Liabilities 102172178205 +15.2%
Fixed Assets 16222216 -27.3%
CWIP 0000 —
Investments 0121313 +0.0%
Other Assets 86138142177 +24.6%
Total Assets 102172178205 +15.2%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 2-8-2-8 -300.0%
Cash from Investing Activity -4-16-32 +166.7%
Cash from Financing Activity 124622 +266.7%
Net Cash Flow -20016 —
Free Cash Flow -3-13-6-4 +33.3%
CFO/OP 34%-49%-1%-31% -3000.0%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 92148129131 +1.6%
Inventory Days 10499126170 +34.9%
Days Payable 79131107127 +18.7%
Cash Conversion Cycle 116117148174 +17.6%
Working Capital Days 868689103 +15.7%
ROCE % 14%13%12%12% +0.0%

👥 Shareholding (latest 4 periods)

Metric Sep 2024Mar 2025Sep 2025Mar 2026 % Chg
Promoters 70.01%70.01%70.01%70.01% +0.0%
Public 29.99%29.99%29.99%29.99% +0.0%
No. of Shareholders 1,6021,4651,2191,060 -13.0%

⚖️ Peer comparison

Industry: Pesticides / Agrochemicals - Indian · 19 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 SHARDACROP Sharda Cropchem ₹725.00 6,541 10.4 5,357 626 19.5% 11.7% 21.9% 123.7% 9.0% -38.4%
2 DHANUKA Dhanuka Agritech ₹961.85 4,288 16.4 1,978 265 19.6% 13.4% -24.5% -36.2% -7.9% -27.3%
3 RALLIS Rallis India ₹198.12 3,853 — — — — — 7.2% -28.4% — —
4 NACLIND NACL Industries ₹136.70 3,202 279.0 1,519 12 7.0% 0.8% 28.3% 105.0% -14.5% 59.8%
5 BHAGCHEM Bhagiradha Chemicals ₹244.25 3,167 115.2 607 28 13.0% 4.5% 21.7% 31.1% 57.6% 235.0%
6 BHARATRAS Bharat Rasayan ₹1,157.40 1,924 13.4 1,203 143 14.6% 11.9% 5.9% 3.3% -10.4% -6.1%
7 INSECTICID Insecticides (India) ₹608.95 1,772 14.2 2,060 125 10.1% 6.1% 7.0% -1.2% -11.5% -24.5%
8 IPL India Pesticides ₹134.99 1,555 14.4 1,033 108 15.9% 10.5% 27.5% 44.4% -8.5% -34.8%
9 ASTEC Astec LifeSciences ₹696.90 1,553 — 441 -67 1.3% -15.1% 17.5% 39.9% -8.3% 43.4%
10 MOL Meghmani Organics ₹57.90 1,472 22.9 2,103 64 9.9% 3.1% 4.5% 371.1% -11.5% 280.0%
11 PUNJABCHEM Punjab Chemicals ₹1,037.20 1,272 19.4 1,058 65 11.8% 6.2% 14.4% 64.3% 8.7% 7.0%
12 EXCELINDUS Excel Industries ₹966.80 1,215 17.0 1,079 71 10.2% 6.6% 11.9% -12.0% -5.1% -12.7%
13 DHARMAJ Dharmaj Crop ₹269.40 910 15.1 1,155 60 9.3% 5.2% 22.5% 91.4% 4.6% 16.8%
14 BESTAGRO Best Agrolife ₹18.99 674 22.6 1,272 30 10.4% 2.3% -30.7% -87.1% 4.0% 103.2%
15 HERANBA Heranba Industries ₹167.20 669 — 1,525 -77 5.7% -5.0% 13.1% -3549.1% -15.3% 11.2%
16 SHIVALIK Shivalik Rasayan ₹350.80 562 38.3 375 20 12.3% 5.2% 18.0% -12.0% 7.9% 59.5%
17 SIKKO Sikko Industries ₹5.85 256 41.9 65 6 12.0% 9.4% 2.3% 109.7% -2.3% 43.4%
18 CLSL Crop Life ₹48.35 83 12.6 207 7 8.2% 3.4% — — -7.4% 33.3%
19 ARISTO Aristo Bio-Tech ₹89.15 61 8.5 363 7 4.4% 1.9% — — 2.9% —
❓ Frequently asked questions
What was Crop Life Science Limited's revenue in Q4 FY26?
Crop Life Science Limited reported revenue of ₹87 crore for the quarter ended March 2026 (Q4 FY26), down 7.4% from ₹94 crore in the same quarter last year.
What was Crop Life Science Limited's net profit in Q4 FY26?
Net profit rose 33.3% year-on-year to ₹4 crore, from ₹3 crore. Earnings per share (EPS) came in at ₹2.19.
What is CLSL's market capitalisation and P/E ratio?
At the current price of ₹64.45, CLSL has a market capitalisation of ₹110 crore and a trailing P/E of about 15.8.
Who owns Crop Life Science Limited? (shareholding pattern)
As of Mar 2026, promoters held 70.01%, public shareholders 29.99% of Crop Life Science Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI